The studies’ overview (n = 7) showed cohorts that primarily included patients with MEN1-related insulinomas (n = 2) or MEN1-associated primary hyperparathyroidism (n = 2) or analyses of genetic testing in MEN1 (n = 3), a wide spectrum of objectives being registered across these data. The gene discussed is MEN1; the disease is pancreatic insulinoma.